On January 8, 2018, STRATA Skin Sciences, Inc. sent a letter to Sabby Management, LLC responding to Sabby Management's letter addressed to the Company's Board of Directors dated January 2, 2018 and the Schedule 13D Sabby Management and its affiliates filed with the Securities and Exchange Commission on January 2, 2018. In the letter, the Company stated that the terms referenced in Sabby Management’s letter regarding a proposed equity investment in the Company by a med-tech investor correctly describe certain facts. The Company stated that Sabby Management’s letter, fails to include other terms sought by the med-tech investor essential to an understanding of its proposed investment. The Company stated that Sabby Management’s letter therefore creates misleading impressions. The Company also stated that it does not know whether Sabby Management were aware of all elements of the proposal when Sabby Management wrote its letter and decided purposely to omit essential terms or were unaware of those terms and thus did not include them. The Company stated that either way, in an effort to address the misleading impressions created by Sabby Management’s letter, the Company calls to Sabby Management attention the following terms of the proposed investment omitted from Sabby Management’s letter.
STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Companyâs products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.
STRATA SKIN SCIENCES, INC. 
